NeoPharm CO., LTD. (KOSDAQ:092730)
South Korea · Delayed Price · Currency is KRW 17,020
-150 (-0.87%)
Jun 10, 2026, 3:30 PM KST
NeoPharm CO., LTD. Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 266,214 | 287,330 | 180,766 | 202,163 | 150,156 | 193,952 | |
Market Cap Growth | 23.33% | 58.95% | -10.58% | 34.63% | -22.58% | -13.13% |
Enterprise Value | 126,391 | 154,628 | 66,098 | 78,166 | 45,545 | 97,728 |
Last Close Price | 17020.00 | 18370.00 | 11384.69 | 11811.25 | 8517.25 | 10615.43 |
PE Ratio | 9.57 | 10.33 | 7.84 | 8.71 | 8.82 | 10.95 |
Forward PE | 8.21 | 8.05 | 8.05 | 8.05 | 8.05 | 10.43 |
PS Ratio | 2.01 | 2.17 | 1.52 | 2.08 | 1.77 | 2.21 |
PB Ratio | 1.36 | 1.47 | 1.02 | 1.26 | 1.06 | 1.49 |
P/TBV Ratio | 1.38 | 1.48 | 1.03 | 1.28 | 1.07 | 1.51 |
P/FCF Ratio | 9.78 | 10.55 | 11.42 | 59.27 | 8.48 | 9.08 |
P/OCF Ratio | 9.37 | 10.11 | 9.70 | 8.69 | 8.27 | 8.95 |
PEG Ratio | - | 5.64 | 5.64 | 5.64 | 5.64 | 5.64 |
EV/Sales Ratio | 0.96 | 1.17 | 0.56 | 0.81 | 0.54 | 1.11 |
EV/EBITDA Ratio | 3.96 | 4.84 | 2.38 | 2.90 | 1.98 | 4.08 |
EV/EBIT Ratio | 4.39 | 5.37 | 2.68 | 3.09 | 2.12 | 4.36 |
EV/FCF Ratio | 4.64 | 5.68 | 4.18 | 22.92 | 2.57 | 4.58 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.06 | 0.06 | 0.02 | 0.04 | 0.02 | 0.02 |
Debt / FCF Ratio | 0.07 | 0.07 | 0.04 | 0.31 | 0.02 | 0.03 |
Net Debt / Equity Ratio | -0.72 | -0.72 | -0.71 | -0.69 | -0.79 | -0.80 |
Net Debt / EBITDA Ratio | -4.38 | -4.38 | -4.53 | -4.11 | -4.90 | -4.37 |
Net Debt / FCF Ratio | -5.14 | -5.14 | -7.95 | -32.52 | -6.39 | -4.89 |
Asset Turnover | 0.64 | 0.64 | 0.64 | 0.58 | 0.57 | 0.64 |
Inventory Turnover | 3.24 | 3.24 | 3.93 | 3.35 | 3.19 | 3.18 |
Quick Ratio | 7.32 | 7.32 | 9.21 | 7.22 | 9.22 | 8.74 |
Current Ratio | 8.40 | 8.40 | 10.12 | 7.94 | 9.99 | 9.39 |
Return on Equity (ROE) | 14.95% | 14.95% | 13.69% | 15.36% | 12.50% | 14.28% |
Return on Assets (ROA) | 8.77% | 8.77% | 8.33% | 9.50% | 8.97% | 10.14% |
Return on Invested Capital (ROIC) | 44.62% | 46.59% | 37.61% | 51.12% | 56.96% | 64.53% |
Return on Capital Employed (ROCE) | 14.60% | 14.60% | 13.90% | 15.80% | 15.10% | 17.20% |
Earnings Yield | 10.45% | 9.68% | 12.76% | 11.48% | 11.34% | 9.13% |
FCF Yield | 10.23% | 9.47% | 8.76% | 1.69% | 11.79% | 11.01% |
Dividend Yield | 4.37% | 4.08% | 5.27% | 3.17% | 4.11% | 3.30% |
Payout Ratio | 33.73% | 33.73% | 25.43% | 23.58% | 32.15% | 28.70% |
Buyback Yield / Dilution | - | - | - | - | - | 0.95% |
Total Shareholder Return | 4.57% | 4.08% | 5.27% | 3.17% | 4.11% | 4.24% |